The company said net revenues for Q3 2024 were $9,911 million ($9,141 million in the same quarter last year), adjusted operating income was $4,153 million, and adjusted diluted EPS was $1.91, up 14.4%. Excluding currency, adjusted diluted EPS rose 18.0%.

1. 01

   The company said net revenues for Q3 2024 were $9,911 million ($9,141 million in the same quarter last year), adjusted operating income was $4,153 million, and adjusted diluted EPS was $1.91, up 14.4%. Excluding currency, adjusted diluted EPS rose 18.0%.

2. 02

   Philip Morris International said it raised its full-year 2024 adjusted diluted EPS growth outlook to $6.45 to $6.51, or 14.0% to 15.0% excluding currency. Reported diluted EPS guidance is $6.20 to $6.26, compared with $5.02 for 2023.

3. 03

   The company said its smoke-free business accounted for 38% of total net revenues and 40% of gross profit in Q3. Smoke-free net revenues rose 14.2% and gross profit rose 15.9%. Heated tobacco unit (HTU) shipments grew 8.9% in Q3, and U.S. ZYN shipments were 149.1 million cans.

4. 04

   PMI said in September 2024 that it agreed to sell its subsidiary Vectura Group Ltd. to Molex Asia Holdings Ltd., and it expects the deal to close by the end of 2024, subject to regulatory approval and other conditions. The company said it recorded an impairment charge of $198 million in Q3 related to Vectura's classification as held for sale.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.